Quantum-Si (NASDAQ:QSI - Get Free Report) is projected to announce its Q1 2026 results after the market closes on Thursday, May 7th. Analysts expect the company to announce earnings of ($0.12) per share and revenue of $0.2990 million for the quarter. Investors can check the company's upcoming Q1 2026 earning summary page for the latest details on the call scheduled for Thursday, May 7, 2026 at 4:30 PM ET.
Quantum-Si (NASDAQ:QSI - Get Free Report) last announced its quarterly earnings data on Tuesday, March 3rd. The company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.14) by $0.06. The business had revenue of $0.45 million during the quarter, compared to analyst estimates of $0.76 million. Quantum-Si had a negative return on equity of 43.90% and a negative net margin of 4,160.06%. On average, analysts expect Quantum-Si to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Quantum-Si Trading Down 5.2%
Shares of Quantum-Si stock opened at $0.86 on Thursday. Quantum-Si has a 12 month low of $0.69 and a 12 month high of $3.10. The business has a fifty day simple moving average of $0.89 and a two-hundred day simple moving average of $1.25. The firm has a market capitalization of $187.12 million, a P/E ratio of -1.66 and a beta of 3.08.
Insider Buying and Selling
In related news, Director Paula Dowdy purchased 109,890 shares of the stock in a transaction dated Thursday, March 5th. The stock was purchased at an average price of $0.95 per share, with a total value of $104,395.50. Following the transaction, the director directly owned 269,107 shares in the company, valued at $255,651.65. This trade represents a 69.02% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Jeffrey Alan Hawkins sold 83,712 shares of Quantum-Si stock in a transaction dated Monday, April 20th. The stock was sold at an average price of $1.01, for a total value of $84,549.12. Following the completion of the transaction, the chief executive officer directly owned 3,776,135 shares of the company's stock, valued at approximately $3,813,896.35. This represents a 2.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 212,904 shares of company stock worth $205,021 in the last 90 days. 22.04% of the stock is owned by company insiders.
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the business. Prudential Financial Inc. purchased a new position in shares of Quantum-Si in the second quarter worth $25,000. Cerity Partners LLC purchased a new position in Quantum-Si in the 2nd quarter worth about $29,000. Dimensional Fund Advisors LP purchased a new position in Quantum-Si in the 4th quarter worth about $34,000. BNP Paribas Financial Markets raised its position in Quantum-Si by 101.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 30,464 shares of the company's stock worth $43,000 after buying an additional 15,331 shares during the last quarter. Finally, State Board of Administration of Florida Retirement System purchased a new position in Quantum-Si in the 4th quarter worth about $45,000. Hedge funds and other institutional investors own 39.90% of the company's stock.
Analysts Set New Price Targets
A number of equities analysts have weighed in on the stock. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Quantum-Si in a research note on Friday, March 27th. Canaccord Genuity Group decreased their target price on shares of Quantum-Si from $1.50 to $1.00 and set a "hold" rating for the company in a research note on Wednesday, March 4th. Two analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $3.25.
Check Out Our Latest Analysis on QSI
Quantum-Si Company Profile
(
Get Free Report)
Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.
Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Quantum-Si, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quantum-Si wasn't on the list.
While Quantum-Si currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.